Advancing outcomes of metastatic HER2-positive breast cancer

Saranya Chumsri

doi:10.1016/S0140-6736(23)00805-X

Advancing outcomes of metastatic HER2-positive breast cancer

Hematology / Oncology / Cancer Center / Breast Clinic

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1746-1747
Number of pages	2
Journal	The Lancet
Volume	401
Issue number	10390
DOIs	https://doi.org/10.1016/S0140-6736(23)00805-X
State	Published - May 27 2023

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(23)00805-X

Cite this

@article{f0437055bc3d4c708604a6dcf144e63f,

title = "Advancing outcomes of metastatic HER2-positive breast cancer",

author = "Saranya Chumsri",

year = "2023",

month = may,

day = "27",

doi = "10.1016/S0140-6736(23)00805-X",

language = "English (US)",

volume = "401",

pages = "1746--1747",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10390",

}

TY - JOUR

T1 - Advancing outcomes of metastatic HER2-positive breast cancer

AU - Chumsri, Saranya

PY - 2023/5/27

Y1 - 2023/5/27

UR - http://www.scopus.com/inward/record.url?scp=85159331017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85159331017&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(23)00805-X

DO - 10.1016/S0140-6736(23)00805-X

M3 - Comment/debate

C2 - 37086743

AN - SCOPUS:85159331017

SN - 0140-6736

VL - 401

SP - 1746

EP - 1747

JO - The Lancet

JF - The Lancet

IS - 10390

ER -

Advancing outcomes of metastatic HER2-positive breast cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this